PHS
CLVS

PFM Health Sciences’s Clovis Oncology, Inc. CLVS Stock Holding History

PFM Health Sciences’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,927,928
Closed -$56.6M – 128
2018
Q3 		$56.6M Sell
1,927,928
-409,297
-18% -$15.8M 0.83% 48
2018
Q2 		$106M Buy
+2,337,225
New +$114M 1.66% 10
2017
Q4 		– Sell
-220,487
Closed -$18.2M – 105
2017
Q3 		$18.2M Sell
220,487
-149,654
-40% -$11.9M 0.36% 74
2017
Q2 		$34.7M Sell
370,141
-636,331
-63% -$38.9M 0.93% 40
2017
Q1 		$64.1M Sell
1,006,472
-272,383
-21% -$16.6M 1.6% 23
2016
Q4 		$56.8M Buy
1,278,855
+510,765
+66% +$18M 1.6% 22
2016
Q3 		$27.7M Sell
768,090
-1,218,492
-61% -$26.1M 0.81% 49
2016
Q2 		$27.3M Buy
1,986,582
+112,198
+6% +$1.64M 0.82% 50
2016
Q1 		$36M Sell
1,874,384
-204,056
-10% -$4.32M 1.11% 30
2015
Q4 		$72.7M Sell
2,078,440
-474,447
-19% -$30.6M 2.21% 15
2015
Q3 		$235M Sell
2,552,887
-160,774
-6% -$13.9M 6.6% 1
2015
Q2 		$238M Buy
2,713,661
+446,905
+20% +$38.3M 6.04% 1
2015
Q1 		$168M Buy
2,266,756
+541,630
+31% +$38.2M 4.64% 1
2014
Q4 		$96.6M Buy
1,725,126
+454,917
+36% +$23.9M 2.26% 13
2014
Q3 		$57.6M Buy
1,270,209
+825,475
+186% +$34.5M 1.33% 28
2014
Q2 		$18.4M Sell
444,734
-632,086
-59% -$32.6M 0.37% 51
2014
Q1 		$74.6M Sell
1,076,820
-1,506,688
-58% -$111M 1.35% 26
2013
Q4 		$156M Buy
2,583,508
+556,600
+27% +$30.3M 3.13% 11
2013
Q3 		$123M Buy
2,026,908
+1,452
+0.1% +$103K 2.97% 11
2013
Q2 		$136M Buy
+2,025,456
New +$91.1M 2.82% 12

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

PFM Health Sciences's CLVS Position: Q4 2018 in Review

PFM Health Sciences sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 1,927,928 shares — an estimated $56.6M sold.

PFM Health Sciences first reported a position in CLVS in Q2 2013 and held it in 20 quarters. The position peaked at $238M in Q2 2015. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

  • PFM Health Sciences reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 1,927,928 Clovis Oncology, Inc. shares in Q4 2018, an estimated $56.6M.
  • PFM Health Sciences first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 20 quarters.
  • PFM Health Sciences's Clovis Oncology, Inc. position peaked at $238M in Q2 2015.
  • 165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.